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Subjectively perceived impairment of taste is a common and distinct symptom of
coronavirus disease 2019 (COVID-19). Large meta-analyses identified this symp-
tom in approximately 50% of cases. However, this high prevalence is not sup-
ported by blinded and validated psychophysical gustatory testing, which showed
a much lower prevalence in up to 26% of patients. This discrepancy may be due
to misinterpretation of impaired retronasal olfaction as gustatory dysfunction.
In addition, we hypothesized that COVID-19–associated hyposmia is involved
in the decrease of gustatory function, as found for hyposmia of different origin.
This indirect mechanism would be based on the central-nervous mutual ampli-
fication between the chemical senses, which fails in COVID-19–associated olfac-
tory loss. However, further research is necessary on how severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2) may directly impair the gustatory path-
way as well as its subjective perception.
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1 INTRODUCTION
The coronavirus severe acute respiratory syndrome-
coronavirus-2(SARS-CoV-2) was described for the first
time in December 2019 and still keeps the entire world
in suspense with massive medical, economic, and social
consequences. The symptoms of coronavirus disease 2019
(COVID-19) are very diverse and not always specific,
but the sudden onset of a subjective loss of smell or
taste is highly suspicious of COVID-19 especially if the
nose is not blocked.1–5 During the last year, knowledge
about olfactory loss in COVID-19 has steadily grown.
Several studies confirmed self-reported hyposmia through
psychophysical testing.6,7 The impaired sense of smell
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has been shown to improve within 1 to 2 months in most
of the patients8 and appears to persist in 5% to 20%.9
A potential pathomechanism has been proposed: The
angiotensin converting enzyme 2 (ACE2) and the serine
protease transmembrane protease, serine 2 (TMPRSS2)
facilitate viral invasion of non-neuronal cells of the olfac-
tory epithelium.10,11 Olfactory neurons, at least in mice,
are presumably damaged indirectly.12
This situation is less conclusive for gustatory dys-
function as a consequence of COVID-19. Many ques-
tions about this symptom remain unclear. In the fol-
lowing, we outline the current state of research and
discuss potential pathomechanisms of hypogeusia in
COVID-19.
Int Forum Allergy Rhinol. 2021;1–7. wileyonlinelibrary.com/journal/alr 1
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2 PREVALENCE OF SELF-REPORTED
GUSTATORY LOSS
According to a meta-analysis including more than 38,000
patients, 43% and 45% of SARS-CoV-2–positive patients
exhibit hyposmia and hypogeusia, respectively.13 In
another meta-analysis, the prevalence of gustatory dys-
function was reported to be even higher, at 48%.14 Affected
patients typically report the simultaneous occurrence of a
sudden loss of smell and taste during the acute infection.15
However, when patients describe a “loss of taste,” they
might indicate an issue with flavor perception rather than
impaired gustation, which encompasses only a limited
number of sensations, including sweet, sour, salty, bitter,
umami, and fatty.16,17
Much of the sensory experience during eating is not only
due to the gustatory qualities but results from retronasal
olfaction.18–20 In a rat model, retronasal olfactory informa-
tion but not orthonasal olfactory input was shown to be
processed in the gustatory cortex.21 In humans, orthonasal
olfactory stimulation with chocolate can stimulate the
insular gustatory cortex in a magnitude comparable to
sweet taste.22
In an effort to disentangle the complaints of COVID-19
patients on taste from effects of smell loss, some studies
asked about specific taste qualities. For example, Parma
et al.15 found that around 65% of COVID-19 patients
reported an impairment of at least one of the taste modali-
ties: sweet, bitter, salty, and sour. This was reported only
by ∼10% of patients with other respiratory disorders. In
another study, COVID-19 patients were given the option to
report changes in specific taste qualities (i.e., salty, sour,
sweet, bitter, or umami/savory) as a “check all that apply”
(CATA) question. Eleven percent (11%) reported impair-
ment of a single taste quality and 48% reported impairment
of two or more taste qualities.4
As already mentioned above, the majority of these pub-
lications are based on the patient’s self-reported taste per-
ception. They were collected during the acute infection
or retrospectively through telephone surveys, online, or
mail questionnaires.13 In theirmeta-analysis, von Bartheld
et al.13 included 60 studies based on rated gustatory func-
tion and only five studies based on various psychophys-
ical measures of gustatory function in COVID-19. The
authors found the prevalence of psychophysically diag-
nosed hyposmia to be 42%, almost the same as the preva-
lence of self-reported gustatory dysfunction (45%). How-
ever, it has to be kept in mind that only one of the five
studies used validated psychophysical tests, whereas the
remaining studies were based on improvised tests of gus-
tatory function.
The limited number of studies which used psychophys-
ical tests to evaluate gustatory function during acute
COVID-19 is largely due to the challenges of chemosensory
testing in COVID-19 patients.23–34 During the acute infec-
tion with SARS-CoV2, patients are quarantined because
of the high risk of spreading the infection. They cannot
visit ear nose and throat (ENT) departments to undergo
validated,mostly operator-performed testing. And because
chemosensory dysfunction improves inmost cases quickly,
testing after infections may not capture the worst impair-
ment experienced by the patient during the disease. The
delay between onset of COVID-19–associated gustatory
dysfunction and gustatory testing might account for por-
tions of the observed difference between reported andmea-
sured gustatory function.
3 IMPROVISED GUSTATORY TESTING
DURING COVID-19
To allow gustatory testing in quarantine, Vaira et al.31
established an improvised suprathreshold taste test. Quar-
antined patients were asked to prepare water-based solu-
tions using salt, sugar, lemon juice, and decaffeinated
coffee. After putting 1 teaspoon of each sample in the
mouth, the patient had to self-evaluate the four major
gustatory qualities sweet, sour, salty, and bitter using a
scale from 0 to 10.29,31 Results from the “homemade” self-
administered test were compared to scores obtained in
a situation where the same taste test was administered
by an operator in an outpatient clinic. Although differ-
ent protocols in terms of testing and scoring were used,
similar gustatory scores were found in both trials.31 These
four studies—two of which included also hospitalized
patients—found an impaired overall taste function in up to
64% of participants.29,31–33 Similarly, Konstantinidis et al.26
used an improvised home-prepared taste test to assess the
course of gustatory dysfunction after COVID-19. They also
found impaired gustation during the acute infection and
an improvement after 4 weeks.26 In another study, patients
self-prepared water-based solutions to test for the qualities
“salty” and “sweet.” With this very simple two-item self-
test, gustatory dysfunctionwas identified in 47%ofCOVID-
19 patients.28
However, these improvised, nonvalidated tests have sig-
nificant weaknesses: First, some of the tests used ingredi-
ents that have a strong smell; for example, lemon for sour
or decaffeinated coffee for bitter. This potentially biases
the identification and evaluation of the respective taste,
because if something smells like coffee, it probably is also
bitter. Second, testing is not blinded so that participants
know exactly what they are confronted with. Third, sub-
jective identifications of suprathreshold tastes are to some
degree questionable because many individuals have diffi-
culties in the correct identification of tastes.35
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4 VALIDATED PSYCHOPHYSICAL
GUSTATORY TESTING DURING COVID-19
Different from improvised taste tests mentioned above, six
studies used blinded and validated psychophysical tests
to assess gustatory function during COVID-19.7,23–25,27,30
Bocksberger et al.23 performed a suprathreshold taste
test (modified, four-item version of “Taste Strip” test36)
in 10 hospitalized COVID-19 patients. They found nor-
mogeusia in all tested patients.23 Hintschich et al.25 sent
the same test to home quarantined patients who used a
standardized, blinded protocol to test themselves. Again,
there were no significant differences in tested gustatory
function between the study group 5 days after a positive
SARS-CoV-2 PCR (n = 41) and SARS-CoV-2 antibody
negative controls (n = 30).25 Cao et al.24 found similar
taste scores for both the SARS-CoV-2–positive patients
and a control group. Singer et al.30 sent the more sophis-
ticated 16-item “Taste Strip” test to home quarantined
patients who tested themselves.36 Even though all 39
patients subjectively reported decreased taste sensitivity,
testing confirmed hypogeusia only in 26%. Two studies
performed an operator-performed taste test: Le Bon et al.27
tested gustatory function through the 16-item “Taste
Strips” and found a preserved gustation in 88% of patients.
Twelve percent (12%) were hyposmic, whereas none were
anosmic.27 Similarly, Niklassen et al.7 showed hypogeusia
in 26% of 61 patients.
Hence, there is a discrepancy between the prevalence
of tested gustatory dysfunction when using two substan-
tially different testing methods: In improvised, often self-
made, and self-administered taste tests, the prevalence
of hypogeusia was similar to rated gustatory function.
It was two to three times higher compared to results
obtainedwith validated and blinded tests. Unless validated
and blinded psychophysical tests miss out on significant
aspects of gustatory functions, improvised “homemade”
tests appear to overestimate gustatory dysfunction during
COVID-19.
5 RECOVERY OF GUSTATORY
FUNCTION
Many studies reported a recovery of gustatory function fol-
lowing COVID-19.7,37,38 Using “homemade” tests, a recov-
ery of gustation could be shown in two studies.26,33 Taste
recovery may occur faster than smell recovery.9 One case
report even mentioned recovery of taste in a chronically
hyposmic patient.39 This could suggest that people are
able to differentiate between olfactory and gustatory sensa-
tions, and that both recovery processes are different. How-
ever, again, these publications on recovery did not use val-
idated psychophysical tests and were based on small sam-
ples/case reports.
6 POSSIBLE PATHOMECHANISMS
Validated and blinded gustatory testing found a lower
prevalence of taste loss compared to subjective reports
and to “homemade” gustatory testing. As mentioned in
the paragraph “Prevalence of self-reported gustatory loss”,
flavor is often mistaken as taste, because “flavor” inte-
grates taste, sounds of mastication, (retronasal) smell, and
trigeminal activation, including temperature, spiciness,
food texture, and mouthfeel.18,19,40 Having said that, there
is clear psychophysical evidence that COVID-19 can affect
gustatory perception. Two studies7,30 used the established
16-item Taste-Strip test and showed the prevalence of taste
dysfunctions to be increased in comparison with the gen-
eral population.41 Similarly, gustatory dysfunction does
occur in postviral, non-COVID-19 conditions, although the
rate of occurrence is low.18,42
There are various hypotheses on possible pathomecha-
nisms of COVID-19–related gustatory dysfunction43–47:
∙ ACE2 allows the cell invasion of SARS-CoV-2.48
Although the oral mucosa also expresses ACE2, it was
unclear whether taste buds also do.43,49,50 A very recent
publication showed not only the expression of ACE2 in
Type II taste receptor cells, but also SARS-CoV-2 in the
same subtype of cells.51 This agrees with the findings of
deteriorated gustatory function after pharmacological
intervention with angiotensin II receptor blockers and
angiotensin-converting enzyme inhibitors.52,53
∙ The salivary glands express high levels of ACE2 and
TMPRSS2.50,54 Moreover, the glandular epithelium is
an early target of SARS-CoV-2.55 Consequently, com-
position and amount of saliva could change and affect
gustation.56 However, in rats, the glandular mucosa
regenerates within approximately 7 days and saliva
changes are not expected to be long-lasting.57 This
is in contrast with the subjective gustatory dysfunc-
tion in COVID-19, which has been found to last a
mean of 18 days and in single cases even longer than
6 months.9
∙ Another possible pathomechanism could be due to
the much-discussed central neurotropism of COVID-19.
SARS-CoV-2 was detected in vivo in the cerebrospinal
fluid and postmortem in various central nervous sys-
tem (CNS) structures.58,59 Clinically, this manifests itself
in various neurological symptoms such as encephali-
tis, seizure, and Guillain-Barré syndrome. However, the
prevalence of neuronal symptoms other than chemosen-
sory dysfunction as well as the detection of SARS-CoV-
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2 is much lower than the prevalence of self-reported
hypogeusia.43,58,60
∙ The so-called “cytokine storm” due to an overshooting
inflammatory response with high levels of tumor necro-
sis factor α (TNF-α), interferon γ (IFN-γ), and inter-
leukin 6 (IL-6) could affect gustation. Because these
cytokines can impair stem cell function, they could also
decelerate cell renewal.43,61,62
7 COMPLEMENTARY HYPOTHESIS
TO HYPOGEUSIA RELATED TO COVID-19
Flavor perception includes the integration of gustatory,
olfactory, and trigeminal information.63 Even though their
afferents enter the CNS through different channels, these
senses share distinct brain projection areas and integrative
processing.40,64–66 They mutually amplify each other and
do not exhibit strong compensation for the impairment of
other chemical senses, as is known for other senses such
as vision and hearing.67
For pre-COVID-19 conditions, it has been shown that
an impaired sense of smell is associated with a decrease
in gustation. In general, in lasting hyposmia, gustatory
function of sweet, sour, salty, and bitter is impaired.68–70
Moreover, Han et al.71 showed impaired gustation for
umami in hyposmic patients. This was confirmed through
a decreased sensitivity to electrogustometric stimuli in
patients with psychophysically confirmed hyposmia com-
pared to a healthy control group.71 However, when acute
hyposmia was induced through mechanical obstruction of
the olfactory cleft, this effect could not be observed.69,72
This gustatory dysfunction in association with lasting
hyposmia is most likely due to a reduced amplification of
gustatory input on a central nervous level.
After COVID-19, impaired olfaction improves in most
cases.73 However, some patients still suffer from olfac-
tory dysfunction weeks after the infection, which has
been confirmed through psychophysical testing.38 Persist-
ing hyposmia due to COVID-19 could potentially lead to
a consecutive dysfunction in gustation as shown before
in posttraumatic, idiopathic, postinfectious, and chronic
rhinosinusitis–related hyposmia.15,70 This is in line with
Huart et al.,74 who conducted psychophysical tests 2 weeks
after the acute SARS-CoV-2 infection and revealed a sig-
nificantly decreased taste function in a group of hypos-
mic patients. Moreover, this idea is supported by recent
work from Le Bon et al.27 showing that 48 of 93 patients
(52%) considered themselves to have abnormal taste func-
tion right before testing, whereas only 12% of them were
found to be dysgeusic following psychophysical evalua-
tion. In their study, they also observed that the olfactory
score—rather than the gustatory score—correlated better
with the patients’ self-assessed taste rating.
8 CONCLUSION
A sudden onset of olfactory and gustatory dysfunction was
characterized as highly suspicious for COVID-19. Their
prevalence was shown to be approximately 50%. However,
it appears that hyposmia and not hypogeusia is the lead-
ing chemosensory symptom in acute COVID-19. Although
taste dysfunction clearly is part of the COVID-19 symp-
toms, up to now, psychophysical evidence confirms the
decreased taste function at a relatively low prevalence. The
pathomechanism of COVID-19–related gustatory dysfunc-
tion due to changes at the level of the oral cavity is still
unclear. However, olfactory dysfunction due to COVID-19
could be associated indirectly with gustatory dysfunction,
as shown for non-COVID-19 hyposmia. Further research
using validated chemosensory tests in combination; for
example, with histopathological methods, are needed to
further explore gustatory involvement in COVID-19.
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